EichorEICHOR
Location: Oslo Synced from ClinicalTrials.gov · August 07, 2026

Clinical studies recruiting near Oslo

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Hav
Phase 3 · Oslo Universitetssykehus Ullevål · Pfizer · NCT05020236A Study of Nipocalimab in Reducing the Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)
Phase 3 · Oslo University Hospital HF Ulleval sykehus · Janssen Research & Development, LLC · NCT06449651Observational Study Protocol: LIVER-R
Phase N/A · Research Site · AstraZeneca · NCT06252753The Remote Monitoring of Gout Feasibility Study in Primary Care
NA · Diakonhjemmet Hospital · Diakonhjemmet Hospital · NCT07490522Empowering Narratives
NA · Kristinia University of Applied Sciences · Kristiania University College · NCT07062042Free Fluid Detection With Telementored eFAST
NA · Oslo university hospital, Rikshospitalet · Oslo University Hospital · NCT06594562A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line
Phase 3 · Oslo Universitetssykehus Rikshospitalet-Avdeling for blodsyk · Merck Sharp & Dohme LLC · NCT06136559Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Phase 3 · Oslo universitetssykehus, Radiumhospitalet ( Site 2002) · Merck Sharp & Dohme LLC · NCT06393374A Study of Roxadustat to Treat Anemia in Children and Teenagers With Chronic Kidney Disease
Phase 3 · Site NO47002 · Astellas Pharma Global Development, Inc. · NCT05970172A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes
Phase 3 · Oslo University Hospital · Vertex Pharmaceuticals Incorporated · NCT04786262Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma (TRIgnite-1)
Phase 1 · Oslo University Hospital · Ichnos Sciences SA · NCT05862012A Study Evaluating the Effects of Filgotinib in Children and Teenagers With Ulcerative Colitis
Phase 3 · Oslo University Hospital HF · Alfasigma S.p.A. · NCT06865417A Multiple Baseline Feasibility Trial of Social Management Training for People With Sex Chromosome Aneuploidies
Phase 1 · Oslo University Hospital · University of Oslo · NCT07718997Lomustine in Addition to Standard of Care in Patients With MGMT Methylated Glioblastoma
Phase 3 · Oslo University Hospital · Vastra Gotaland Region · NCT06419946Assessment of Short Immunotherapy After Radical Surgery of High-risk Malignant Melanoma
Phase 3 · Akershus University Hospital · Uppsala University · NCT06488482PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease
Phase 2 · Oslo Universitetssykehus HF, Ulleval sykehus · Boehringer Ingelheim · NCT07355296Home-Based Clinical Management of Cardiac Complications in Systemic Sclerosis
Phase N/A · Oslo University Hospital · Oslo University Hospital · NCT06865118Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
Phase 3 · Oslo Universitetssykehus · PedAL BCU, LLC · NCT05183035Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Ag
Phase 1 · Oslo Universitetssykehus Ulleval /ID# 275433 · AbbVie · NCT06896916A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advance
Phase 1/Phase 2 · GSK Investigational Site · GlaxoSmithKline · NCT06885034A Trial of Nicotinamide/Pterostilbene Supplement in ALS: The NO-ALS Extension Study
NA · Oslo Univerity Hospital · Haukeland University Hospital · NCT05095571Does BIO-RSA Provides Superior Clinical Outcome Compared to Conventional RSA?
NA · Lovisenberg Diaconal Hospital · Lovisenberg Diakonale Hospital · NCT06025331SAINT: Safe Induction of Labor Trial
Phase 3 · Oslo University Hospital Rikshospitalet · Oslo University Hospital · NCT05719467Comparison of CT and MR (VI-RADS) Imaging for Local Bladder Cancer Staging
Phase N/A · Oslo University Hospital · Oslo University Hospital · NCT07602010Heart Rate Informed Changes in Care for Non-Communicating Patients
NA · Oslo University Hospital · University of Oslo · NCT05738278Chemoradiotherapy Followed by Planned Surgery or by Surveillance and Surgery Only When Needed for Oesophageal Cancer
Phase 3 · Oslo universitetssykehus · Karolinska University Hospital · NCT04460352A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Pati
Phase 2 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT06581198Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS
Phase 3 · Oslo universitetssykehus, Radiumhospitalet · Eli Lilly and Company · NCT06890598Bortezomib and Temozolomide in Recurrent Grade-4 Glioma Unmethylated MGMT Promoter (BORTEM-17)
Phase 1/Phase 2 · Oslo University Hospital · Haukeland University Hospital · NCT03643549A Study to Determine the Recommended Dose and Schedule, and Evaluate the Safety and Preliminary Efficacy of Mezigdomide
Phase 1/Phase 2 · Sykehusapoteket Ull · Celgene · NCT06988488
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.